TRAVELLER: A study to assess your potential eligibility for Roche Alzheimer's disease clinical studies

This is a screening trial to determine if people are eligible for a Roche Alzheimer’s disease clinical study where treatments are being tested. 

You may be able to participate in the TRAVELLER study if you:

• Are between 50-90 years of age. 
• Have had concerns about your memory OR
• Have been diagnosed with mild cognitive impairment or mild dementia due to Alzheimer’s disease within the last year
   

The trial consists of a 2 hour visit. During the trials you will; 

• discuss and then sign the Informed Consent Form with our doctor
• answer questions about your medical history, medications, personal status (age, gender, race, ethnicity) and demographics. 
• complete a short memory assessment 
• have a blood test taken to test for pTau levels (which is linked to Alzheimer's disease).
   

If your results show that you are a suitable candidate for a Roche clinical study, you will be referred to the study team for further information and screening for a drug trial.